These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15765429)

  • 61. Dyspepsia.
    Desai HG
    J Assoc Physicians India; 2012 Mar; 60 Suppl():5. PubMed ID: 23155795
    [No Abstract]   [Full Text] [Related]  

  • 62. Gastric high-grade dysplasia.
    Testino G; Sumbaraz A; Emilio D; Valentini M; Cornaggia M
    Gastroenterology; 1999 Jul; 117(1):285-6. PubMed ID: 10428617
    [No Abstract]   [Full Text] [Related]  

  • 63. Omeprazole and excessive sweating, if unrecognised, may lead to unnecessary investigations.
    Mamun M; Caddick S; Siddiqi MA
    Postgrad Med J; 1999 Nov; 75(889):701-2. PubMed ID: 10621892
    [No Abstract]   [Full Text] [Related]  

  • 64. Modified
    Tepeš B; Malfertheiner P; Labenz J; Aygen S
    World J Gastroenterol; 2017 Aug; 23(32):5954-5961. PubMed ID: 28932087
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recurrent hypomagnesemia with proton-pump inhibitor rechallenge.
    Quasdorff M; Mertens J; Dinter J; Steffen HM
    Ann Intern Med; 2011 Sep; 155(6):405-7. PubMed ID: 21930865
    [No Abstract]   [Full Text] [Related]  

  • 66. [Costs and effectiveness of diagnosis and treatment of patients with dyspepsia, determined with the aid of a computer model].
    Schipper CK; Rutten FF; Loffeld RJ
    Ned Tijdschr Geneeskd; 1993 Aug; 137(35):1767-71. PubMed ID: 8371821
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapeutic strategies for the treatment of dyspepsia.
    Kandulski A; Venerito M; Malfertheiner P
    Expert Opin Pharmacother; 2010 Oct; 11(15):2517-25. PubMed ID: 20726822
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test.
    Armstrong D; Veldhuyzen SJ; Chung SA; Shapiro CM; Dhillon S; Escobedo S; Chakraborty BK; Mann V; Tanser L; Nevin K
    Can J Gastroenterol; 2005 Jun; 19(6):350-8. PubMed ID: 15997268
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis.
    Ford AC; Qume M; Moayyedi P; Arents NL; Lassen AT; Logan RF; McColl KE; Myres P; Delaney BC
    Gastroenterology; 2005 Jun; 128(7):1838-44. PubMed ID: 15940619
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Letter: the effects of overlapping symptoms on the response to PPI therapy in GERD.
    Kennedy M; Ford AC
    Aliment Pharmacol Ther; 2012 Jul; 36(2):207; author 207-8. PubMed ID: 22703466
    [No Abstract]   [Full Text] [Related]  

  • 71. The role of Helicobacter pylori in nonulcer dyspepsia. A debate--against.
    Talley NJ
    Gastroenterol Clin North Am; 1993 Mar; 22(1):153-67. PubMed ID: 8449564
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of dialysis on gastroesophageal reflux, dyspepsia, and proton pump inhibitor treatment in patients with chronic renal failure.
    Strid H; Fjell A; Simrén M; Björnsson ES
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):137-42. PubMed ID: 19212202
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Update on the evaluation and management of functional dyspepsia.
    Loyd RA; McClellan DA
    Am Fam Physician; 2011 Mar; 83(5):547-52. PubMed ID: 21391521
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Management of Dyspepsia.
    Feld L; Cifu AS
    JAMA; 2018 May; 319(17):1816-1817. PubMed ID: 29715342
    [No Abstract]   [Full Text] [Related]  

  • 75. A review of drug therapy for functional dyspepsia.
    Chen SL
    J Dig Dis; 2013 Dec; 14(12):623-5. PubMed ID: 23957752
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Proton pump inhibitors, a family of drugs in continuous expansion].
    Pellicano R
    Minerva Gastroenterol Dietol; 2000 Dec; 46(4):231-41. PubMed ID: 19320085
    [No Abstract]   [Full Text] [Related]  

  • 77. Oral proton-pump inhibitors and step-down therapy for nonulcer dyspepsia: is this the right approach?
    Waldum HL; Martinsen TC; Hauso O; Qvigstad G
    Therap Adv Gastroenterol; 2010 Mar; 3(2):73-6. PubMed ID: 21180591
    [No Abstract]   [Full Text] [Related]  

  • 78. Stress-induced changes in healthy mice do not reflect functional dyspepsia pathophysiology.
    Ceulemans M; Wauters L; Accarie A; Vanuytsel T
    Neurogastroenterol Motil; 2020 Sep; 32(9):e13940. PubMed ID: 32671945
    [No Abstract]   [Full Text] [Related]  

  • 79. Proton-pump inhibitor overuse: a cautionary tale in misguided benefit.
    Nath K; Reyaldeen R; Palamuthusingam D
    Intern Med J; 2019 Oct; 49(10):1337. PubMed ID: 31602763
    [No Abstract]   [Full Text] [Related]  

  • 80. Thermal care of functional dyspepsia based on bicarbonate-sulphate-calcium water: a sequential clinical trial.
    Rocca G; Dioni F; Rocca N; Oliveri F; Brunetto MR; Bonino F
    Evid Based Complement Alternat Med; 2007 Sep; 4(3):381-91. PubMed ID: 17965771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.